TFP Fertility Group acquires Manchester Fertility Group

TFP Fertility Group has acquired Manchester Fertility Group, expanding its UK operations and presence in northwest England.

Financial terms were not disclosed.

TFP operates fertility and reproductive health clinics in the UK and Poland and has more than 35 years of clinical heritage.

Manchester Fertility Group has provided fertility services since 1986 and operates a purpose-built clinic and laboratory in Cheadle, Greater Manchester.

The business comprises five brands: Manchester Fertility, Essential Fertility, Semovo, Egg Donors UK and BuySperm.

Together, they provide fertility treatment, preservation and donor services to patients and partner clinics across the UK.

TFP said the acquisition would broaden its geographic reach and combine complementary clinical capabilities as it seeks to expand access to fertility care.

Jude Fleming, group chief executive officer of TFP Fertility Group, said: “Manchester Fertility has built an excellent reputation over many years, supported by an experienced team and a deep commitment to its patients.

“We see a natural fit between our businesses, with a shared focus on clinical excellence and patient-centred care. By bringing our teams together, we will be able to build on these strengths and expand access to high-quality fertility care across the UK.”

Debbie Falconer and Jonathan Koslover, shareholders of Manchester Fertility Group, said: “We are incredibly proud of what we have built at Manchester Fertility and, in particular, of the dedicated team that has made the business what it is today.

“In TFP, we believe we have found an excellent long-term home for the business and a partner that shares our values and vision for its future. We look forward to seeing Manchester Fertility continue to thrive as part of the wider group.”

TFP is backed by Amulet Capital Partners, a US private equity firm focused on healthcare investments.

TFP and Amulet were advised by Lincoln International and McDermott Will & Schulte on the transaction.

Manchester Fertility Group was advised by Clearwater International and Weightmans LLP.